Can a short course of letrozole before surgery help shrink hormone-sensitive breast cancer?

If you're a postmenopausal woman just diagnosed with a common, hormone-sensitive type of breast cancer, your treatment plan might soon include a short, powerful step before surgery. This study looked at giving the drug letrozole for just 1 to 4 weeks before the scheduled operation to remove the tumor. The goal was to see if this brief pre-surgical treatment could slow down the cancer's growth in a meaningful way. Doctors took a small sample of the tumor with a needle biopsy at diagnosis. Then, after the patient took letrozole daily, they took another sample on the day of surgery to compare. The main thing they measured was a protein in the cancer cells called Ki67, which acts like a gauge of how fast the cells are dividing. By comparing the Ki67 levels before and after the letrozole course, researchers could see how much the drug affected the cancer's activity in a short time. This isn't meant to replace standard surgery or long-term therapy, but it gives doctors a real-time snapshot of how a patient's specific cancer responds to hormone-blocking treatment. Understanding this initial response could help inform decisions about further treatment after surgery.